Complete response to nivolumab monotherapy in a treatment-naive, BRAF wild-type patient with advanced mucosal melanoma and elevated lactate dehydrogenase: a case report from a phase III trial
Crossref DOI link: https://doi.org/10.1007/s00262-016-1898-2
Published Online: 2016-09-07
Published Print: 2016-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ascierto, Paolo A.
Vanella, Vito
Grimaldi, Antonio Maria
Lucia, Festino
Palla, Marco
Simeone, Ester
Mozzillo, Nicola
Funding for this research was provided by:
Bristol-Myers Squibb
License valid from 2016-09-07